Julie B Prillinger
Overview
Explore the profile of Julie B Prillinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gutfinger D, Sultan I, Ailawadi G, Ramzy D, Kaneko T, Yu Y, et al.
Cardiovasc Revasc Med
. 2024 Nov;
PMID: 39487078
Background: Bioprosthetic surgical aortic valve replacement (SAVR) using the Trifecta valve was frequently chosen because of its large opening area and low transvalvular gradient. However, long-term follow-up revealed the potential...
2.
Rodriguez E, Smith R, Castro L, Baker C, Yu Y, Prillinger J, et al.
Ann Thorac Surg
. 2024 Aug;
PMID: 39147118
Background: Bioprosthetic surgical mitral valve replacement (SMVR) remains an important treatment option in the era of transcatheter valve interventions. This study presents 10-year clinical outcomes of Medicare beneficiaries who underwent...
3.
Bergmark B, Osborn E, Ali Z, Gupta A, Kolli K, Prillinger J, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(2):100556.
PMID: 39129806
Background: Use of intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during percutaneous coronary intervention (PCI) is endorsed by society guidelines, but US data on real-world outcomes are lacking. Methods:...
4.
Wiechmann R, Lee L, Yu Y, Prillinger J, Gutfinger D, Blakeman B
JTCVS Open
. 2023 Jan;
12:84-102.
PMID: 36590734
Objective: Bioprosthetic surgical aortic valve replacement remains an important treatment option in the era of transcatheter interventions. Real-world outcomes are not well characterized because of limited prospective follow-up studies. We...
5.
Shavelle D, Heywood T, Srivastava A, Agarwal R, Prillinger J, Roberts G, et al.
Am J Cardiol
. 2022 Sep;
184:90-95.
PMID: 36163050
The objective of this study was to assess ambulatory hemodynamics after transcatheter edge-to-edge repair (TEER) of the mitral valve. Pulmonary artery pressure (PAP) measurements from implanted sensors were collected through...
6.
Vemulapalli S, Kerr M, Roberts G, Prillinger J, Meduri C, McCarthy P
Am Heart J
. 2021 Dec;
245:100-109.
PMID: 34932999
Background: Tricuspid valve disease (TVD) is presumed common, however, little is known about its prevalence or the impact of tricuspid valve surgery (TVS) on healthcare resource use. Methods: To describe...
7.
Tang G, Estevez-Loureiro R, Yu Y, Prillinger J, Zaid S, Psotka M
J Am Heart Assoc
. 2021 Apr;
10(8):e019882.
PMID: 33821669
Background Edge-to-edge transcatheter mitral valve repair as salvage therapy in high surgical risk patients with severe mitral regurgitation presenting with cardiogenic shock (CS) has been described in small case series,...
8.
Mittal S, Musat D, Hoskins M, Prillinger J, Roberts G, Nabutovsky Y, et al.
J Interv Card Electrophysiol
. 2018 Mar;
51(3):221-228.
PMID: 29492807
Purpose: The purpose of the current study is to characterize and quantify the impact of complete atrioventricular block (cAVB) on heart failure hospitalization (HFH) and healthcare utilization in pacemaker (PM)...
9.
Mittal S, Musat D, Hoskins M, Prillinger J, Roberts G, Nabutovsky Y, et al.
J Am Heart Assoc
. 2017 Nov;
6(12).
PMID: 29180458
Background: Patients with atrial fibrillation (AF) often undergo AV junction ablation (AVJA) and pacemaker implantation. Right ventricular (RV) pacing contributes to increased risk of heart failure (HF), which may be...
10.
Merchant F, Hoskins M, Musat D, Prillinger J, Roberts G, Nabutovsky Y, et al.
Circ Cardiovasc Qual Outcomes
. 2017 Jun;
10(6).
PMID: 28630373
Background: Although right ventricular pacing can contribute to cardiomyopathy, the impact of complete atrioventricular block (cAVB) on heart failure (HF) development in pacemaker patients has not been well characterized. We...